XML 22 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Additional paid-in capital
Retained earnings (Accumulated Deficit)
Class A
Common Stock
Class B
Common Stock
Restricted stock units
Restricted stock units
Additional paid-in capital
Performance Shares
Performance Shares
Additional paid-in capital
Beginning balance (in shares) at Dec. 31, 2022 [1]       373,471 36,973,876        
Beginning balance at Dec. 31, 2022 [1] $ 59,004,036 $ 1,422,630 $ 57,577,672 $ 37 $ 3,697        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Distributions and net transfer to shareholders and Other Affiliates (4,193,093)   (4,193,093)            
Stock-based compensation expense 2,571,106 2,571,106              
Taxes related to net share settlement of performance stock units 0                
Forfeiture of private placement warrants 890,001 890,001              
Issuance of common stock upon the reverse recapitalization, net of transaction costs (in shares)       8,492,528          
Issuance of common stock upon the reverse recapitalization, net of transaction costs 17,589,874 17,589,024   $ 850          
Issuance of common stock related to PIPE Investment (in shares)       1,333,962          
Issuance of common stock related to PIPE Investment 9,501,915 9,501,782   $ 133          
Issuance of common stock related to lock-up agreement (in shares)       421,099          
Issuance of common stock related to lock-up agreement 4,236 4,194   $ 42          
Recognition of derivative liability related to earnout (242,211,404) (242,211,404)              
Recognition of derivative liability related equity incentive plan (1,279,139) (1,279,139)              
Earnout stock-based compensation expense for UHG employee options 4,448,077 4,448,077              
Transaction costs related to reverse recapitalization (2,932,426) (2,932,426)              
Reclassification of negative APIC related to the reverse recapitalization $ 0 212,426,727 (212,426,727)            
Exercise of stock options (in shares) 2,053     13,202          
Exercise of stock options under the 2023 Plan $ 133,979 133,978   $ 1          
Forfeiture of stock options under the 2023 Plan 487,739 487,739              
Exercise of stock warrants (in shares)       748,020          
Exercise of stock warrants 0 (75)   $ 75          
Transaction costs related to equity issuance (257,721) (257,721)              
Net income 125,060,284   125,060,284            
Ending balance (in shares) at Dec. 31, 2023       11,382,282 36,973,876        
Ending balance at Dec. 31, 2023 (31,182,536) 2,794,493 (33,981,864) $ 1,138 $ 3,697        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based compensation expense 6,475,649 6,475,649              
Issuance of shares related to restricted stock units (in shares)       23,794          
Issuance of shares related to restricted stock units 0 (2)   $ 2          
Taxes related to net share settlement of restricted stock units           $ (28,202) $ (28,202) $ (22,633) $ (22,633)
Issuance of shares related to performance stock units (in shares)       5,567          
Issuance of shares related to performance stock units 0 (1)   $ 1          
Taxes related to net share settlement of performance stock units (22,633)                
Recognition of derivative liability related equity incentive plan $ (211,370) (211,370)              
Exercise of stock options (in shares) 25,954     26,514          
Exercise of stock options under the 2023 Plan $ 77,227 77,225   $ 2          
Forfeiture of stock options under the 2023 Plan 8,368 8,368              
Exercise of stock warrants (in shares)       10,168,850          
Exercise of stock warrants 44,844,629 44,843,612   $ 1,017          
Net income 46,905,740   46,905,740            
Ending balance (in shares) at Dec. 31, 2024       21,607,007 36,973,876        
Ending balance at Dec. 31, 2024 $ 66,866,872 $ 53,937,139 $ 12,923,876 $ 2,160 $ 3,697        
[1] The shares of the Company’s common stock, prior to the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 373.47:1 (“Exchange Ratio”) established in the Business Combination.